A federal whistleblower lawsuit filed under the U.S. False Claims Act accuses four major academic publishers — Elsevier, Springer Nature, Wiley, and Informa — of running a decade-long scheme to overcharge article processing charges (APCs) on federally funded research, allegedly causing U.S. institutions to submit false reimbursement claims to the government. These are allegations made in a civil complaint, not findings of fact or a court ruling, and the publishers named have not been found liable for anything at this stage.
What the complaint alleges
The suit was filed under seal in March 2024 in the U.S. District Court for the District of Massachusetts by Juan Pablo Alperin, a professor at Simon Fraser University and co-director of the Scholarly Communications Lab in Vancouver, according to reporting by Retraction Watch. Alperin is represented by attorneys Eugenie Reich and John R. Thomas. University of Ottawa researcher Stefanie Haustein was originally named as a co-relator but was dropped from the case shortly before it was unsealed. Sage was also originally named as a defendant but was removed after Alperin determined the publisher had far fewer qualifying articles than the four remaining defendants.
The complaint alleges that Elsevier, Springer Nature, Wiley, and Informa charged APCs “up to 10 times the cost of processing the articles,” with the complaint citing actual per-article processing costs in the range of roughly $200 to $1,000, against APCs the suit says have run as high as $10,000 per paper at the upper end. The theory of the case is that federal public-access mandates — which require many federally funded researchers to make their resulting papers openly available, often by paying an APC — gave publishers a captive market of “unknowing” principal investigators under career pressure to publish in established venues, and that publishers passed the resulting inflated charges through to federal grant funds knowing those charges would be reimbursed as allowable costs. The complaint also alleges Alperin found records of discussions among publishers about strategies to limit the viability of free open-access alternatives, which — if the allegation is accurate — would have helped preserve APC revenue rather than lose it to no-fee routes to compliance. None of this has been tested in court, and each of these are contested claims the defendants have not yet had to answer in litigation.
Why a False Claims Act theory, specifically
The federal False Claims Act is a qui tam statute: it lets a private individual (a “relator”) sue on behalf of the U.S. government over fraud involving federal funds, and, if the case succeeds, share in whatever the government recovers. Because so much APC spending on federally funded papers is ultimately paid out of grant budgets — and because those grants are themselves federal funds subject to allowable-cost rules — an FCA theory turns a pricing dispute into a fraud-on-the-government claim. That is a materially higher bar than an antitrust or consumer-pricing complaint, and it is also why FCA cases in research settings can carry very large exposure when they succeed: Retraction Watch’s report notes, for context on the statute’s scale rather than as a comparison of merits, that a December 2025 FCA settlement involving Dana-Farber Cancer Institute totaled $15 million, and a separate, unrelated FCA settlement involving Duke University over data-integrity issues in grant applications reached $112.5 million. Those figures illustrate what the statute can produce in a research-institution context; they say nothing about how this specific case against these four publishers will be resolved.
Where the case stands
Because it was filed under the FCA, the complaint was filed under seal in March 2024, giving the Department of Justice time to investigate and decide whether to intervene and take over the prosecution itself — something DOJ does in only a minority of qui tam cases. According to Retraction Watch, the government notified the court on July 23, 2026 that it was declining to intervene, and a judge ordered the complaint unsealed on July 30, 2026. Declining to intervene is not the same as the government finding the claims meritless; DOJ passes on the large majority of qui tam suits for resource and prioritization reasons, and Alperin is now entitled to pursue the case independently as relator, with his own counsel bearing the litigation cost and risk.
Asked for comment by Retraction Watch, Springer Nature said it could not comment immediately, Wiley and Elsevier both declined to comment, and Informa had not responded as of publication. None of the four defendants has, as of this writing, filed a public response to the complaint’s substance, and no answer or motion to dismiss had been reported at the time of Retraction Watch’s article.
Why this matters for research administrators and OA officers
Whatever the eventual outcome, the case puts a legal-exposure frame on a cost category that research offices, libraries, and grants offices have mostly treated as a straightforward line-item compliance question: does this APC come out of allowable grant funds, and does the resulting paper meet the funder’s public-access terms. An FCA theory reframes APC payment as a potential fraud vector on the payer side of that transaction, which is a different institutional risk question than “is this APC affordable” or “does this journal satisfy our funder’s OSTP public-access requirements.” Litigation under a qui tam statute typically produces a multi-year sequence of public, searchable milestones — an answer or motion to dismiss, discovery disputes, potential amendment of the complaint, and, in a minority of cases, settlement or trial — so this is very unlikely to resolve quickly in either direction.
For background on how APCs are set and what they nominally fund, see CASRAI’s guide to article processing charges (APCs) for open access. For the funder mandates that make APC payment relevant to federal compliance in the first place, see our guides to OSTP and U.S. public-access policy and to Plan S, the funder open-access mandate most directly associated with pushing APC-based gold and hybrid open access. On the specific publishing model the complaint’s cost estimates concern, see our guide to hybrid open-access journals and our dictionary entry on bronze open access, one of the no-APC routes the complaint alleges publishers had an incentive to keep marginal.
What to watch next
- A defendant response. None of Elsevier, Springer Nature, Wiley, or Informa had filed a substantive public answer to the complaint as of Retraction Watch’s July 31, 2026 report; a motion to dismiss or answer will be the first real test of the theory’s legal viability.
- Whether other publishers or relators join or file parallel actions. Sage was named and then dropped from this specific complaint; whether it or other publishers face separate or amended claims is unresolved.
- Any institutional guidance from research offices or library consortia on how (or whether) this changes APC-payment practices from federal grant funds while the case is pending — none has been reported as of this writing.
FAQ
Is this a finding that the publishers committed fraud?
No. It is a civil complaint filed by a private relator under the False Claims Act. The allegations have not been tested in court, no publisher has been found liable, and the defendants have not yet filed a public response to the complaint’s substance.
Why did the U.S. government decline to intervene?
The Department of Justice investigates qui tam complaints under seal and can choose to take over the case itself or let the relator proceed independently. According to Retraction Watch, DOJ notified the court on July 23, 2026 that it was declining to intervene. Non-intervention is common in FCA cases generally and is not itself a comment on the merits.
Who is the plaintiff?
Juan Pablo Alperin, a professor at Simon Fraser University and co-director of the Scholarly Communications Lab, filed the case as relator in March 2024. A second researcher, Stefanie Haustein of the University of Ottawa, was originally a co-relator but was dropped from the case shortly before it was unsealed.
